Antitumor activity of the selective epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) Iressa® (ZD1839) in an EGFR-expressing multidrug-resistant cell line in vitro and in vivo
Ichiro Naruse, Tohru Ohmori, Yoko Ao, Hisao Fukumoto, Toshio Kuroki, Masatomo Mori, Nagahiro Saijo, Kazuto NishioVolume:
98
Year:
2002
Language:
english
Pages:
6
DOI:
10.1002/ijc.10173
File:
PDF, 216 KB
english, 2002